greeksoup/ stock research

HCA Healthcare (HCA) FY2021 results: revenue $58.8 billion, up 14.0% on the year

HCA Healthcare, Inc. (HCA) reported revenue of $58.8 billion for fiscal 2021, the year ended 31 December 2021, up 14.0% on the year before. Net income was $7.0 billion, up 85.3%, and diluted earnings per share $21.16. The figures are the company's own, from the 10-K it filed with the SEC on 18 February 2022.

Revenue
$58.8 billion
+14.0% on the year
FY2016FY2021
Operating margin
16.7%
10.5% a year earlier
FY2016FY2021
Net income
$7.0 billion
+85.3% on the year
FY2016FY2021
Diluted EPS
$21.16
+93.6% on the year
FY2016FY2021

this yearthe year beforeHover a bar for its figure.

The year in brief

The quarters: Q4 FY2021

Income statement (profit and loss)

$ millionFY2021FY2020FY2019On the yearLast 8 years
Revenue58,75251,53351,336+14.0%
Operating income9,8335,4305,244+81.1%
Operating margin16.7%10.5%10.2%
Interest expense1,5661,5841,824-1.1%
Pre-tax income9,8335,4305,244+81.1%
Income tax2,1121,0431,099+102.5%
Effective tax rate21.5%19.2%21.0%
Net income6,9563,7543,505+85.3%
Net margin11.8%7.3%6.8%
Diluted EPS$21.16$10.93$10.07+93.6%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2021FY2020FY2019On the yearLast 8 years
Operating cash flow8,9599,2327,602-3.0%
Capital expenditure3,5772,8354,158+26.2%
Free cash flow5,3826,3973,444-15.9%
Free cash flow margin9.2%12.4%6.7%
Cash from investing-2,643-3,393-5,720
Cash from financing-6,655-4,677-1,771
Depreciation and amortisation2,8532,7212,596+4.9%
Share-based compensation440362347+21.5%
Buybacks8,2154411,031+1,762.8%
Dividends paid624153550+307.8%
Dividend per share$1.92$0.43$1.60+346.5%
Diluted shares, weighted329m344m348m-4.3%
Shares outstanding at period end305m339m338m-10.0%

Balance sheet

$ millionFY2021FY2020FY2019On the yearLast 8 years
Shareholders' equity-933572-2,808
Non-controlling interest2,4222,3202,243+4.4%
Debt34,57931,00433,722+11.5%
Operating lease liabilities1,7551,6731,499+4.9%
Finance lease liabilities577494470+16.8%
Other liabilities12,34211,4279,932+8.0%
Total liabilities and equity50,74247,49045,058+6.8%
Fixed assets24,06323,19922,715+3.7%
Investments541504462+7.3%
Cash and equivalents1,4511,793621-19.1%
Receivables8,0957,0517,380+14.8%
Inventory1,9862,0251,849-1.9%
Other assets14,60612,91812,031+13.1%
Total assets50,74247,49045,058+6.8%

10-K for the year ended 31 December 2021, filed 18 February 2022: the filing.